Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhTNK-tPA vs rt-PA in ultra-early acute ischemic stroke
CTR20180447Phase 2Completed
- Sponsor
- Guangzhou Mingkang Bioengineering
- Start
- May 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of tenecteplase in ischemic stroke, sponsored by Guangzhou Mingkang Bioengineering. Started May 2018; status: completed.
02
Drugs
tenecteplase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on CTR20180447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20180447.